Integration of genetics and MRD to define low risk patients with B-cell precursor acute lymphoblastic leukaemia with intermediate MRD levels at the end of induction

Moorman, AV; Enshaei, A; Murdy, D; Joy, M; Boer, JM; den, Boer, ML; Pieters, R; de, Haas, V; Horstmann, MA; Escherich, G; Johansson, B; Marquart, HV; Schmiegelow, K; Hancock, J; Moppett, J; Heyman, M

doi:10.1038/s41375-024-02329-0

Integration of genetics and MRD to define low risk patients with B-cell precursor acute lymphoblastic leukaemia with intermediate MRD levels at the end of induction

Lookup NU author(s): Professor Anthony Moorman ORCiD, Dr Amir Enshaei ORCiD, Daniel Murdy, Melvin Joy ORCiD

Downloads

Published version [.pdf]

Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).

Publication metadata

Author(s): Moorman AV, Enshaei A, Murdy D, Joy M, Boer JM, den Boer ML, Pieters R, de Haas V, Horstmann MA, Escherich G, Johansson B, Marquart HV, Schmiegelow K, Hancock J, Moppett J, Heyman M

Publication type: Letter

Publication status: Published

Journal: Leukemia

Year: 2024

Pages: epub ahead of print

Online publication date: 05/07/2024

Acceptance date: 26/06/2024

ISSN (print): 0887-6924

ISSN (electronic): 1476-5551

Publisher: Springer Nature

URL: https://doi.org/10.1038/s41375-024-02329-0

DOI: 10.1038/s41375-024-02329-0

Data Access Statement: Supplementary information The online version contains supplementary material available at https://doi.org/10.1038/s41375-024-02329-0

ePrints

Integration of genetics and MRD to define low risk patients with B-cell precursor acute lymphoblastic leukaemia with intermediate MRD levels at the end of induction

Downloads

Licence

Publication metadata

Share